| Lamotrigine |
20050167 |
EPITRIGINE, Tablet, 100, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма Дупница АД; Actavis hf, Iceland |
8.33 |
1.67 |
10 |
7% |
0.58 |
8.91 |
1.78 |
10.69 |
20% |
1.67 |
10.58 |
2.12 |
12.7 |
|
НСР-1899/27.11.2013 |
17.12.2013 |
17.12.2013 |
Неактивен |
2324 |
| Lamotrigine |
II-10573/29.03.2005 |
EPITRIGINE, Tablet, 50, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма Дупница АД; Actavis hf, Iceland |
5.63 |
1.13 |
6.76 |
7% |
0.39 |
6.02 |
1.2 |
7.22 |
20% |
1.13 |
7.15 |
1.43 |
8.58 |
|
КЦ-507/06.02.2009 |
19.02.2009 |
19.02.2009 |
Неактивен |
472 |
| Lamotrigine |
II-10574/ 29.03.2005 |
EPITRIGINE, Tablet, 100, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма Дупница АД; Actavis hf, Iceland |
8.51 |
1.7 |
10.21 |
7% |
0.6 |
9.11 |
1.82 |
10.93 |
20% |
1.7 |
10.81 |
2.16 |
12.97 |
|
КЦРР-1119/02.08.2012 |
17.08.2012 |
17.08.2012 |
Неактивен |
2324 |
| Lamotrigine |
II-10574/29.03.2005 |
EPITRIGINE, Tablet, 100, mg, Pack: 30 |
Актавис EАД, България |
Балканфарма Дупница АД; Actavis hf, Iceland |
11.81 |
2.36 |
14.17 |
8% |
0.94 |
12.75 |
2.55 |
15.3 |
20% |
2.36 |
15.11 |
3.02 |
18.13 |
|
КЦ-507/06.02.2009 |
19.02.2009 |
19.02.2009 |
Неактивен |
2324 |
| Lamivudine |
EU/1/96/015/003 |
Epivir, Film coated tablet, 300, mg, Pack: 30 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations), Великобритания; GlaxoSmithKline
Pharmaceuticals S.A., Полша |
106.73 |
21.35 |
128.08 |
4% |
4.27 |
111 |
22.2 |
133.2 |
16% |
17.08 |
128.08 |
25.62 |
153.7 |
|
НСР-17658/02.01.2019 |
17.01.2019 |
02.02.2019 |
Активен |
16404 |
| Lamivudine |
EU/1/96/015/001 |
EPIVIR, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom, GlaxoSmith Kline Pharmaceuticals S.A. Poland |
103.05 |
20.61 |
123.66 |
4% |
4.12 |
107.17 |
21.43 |
128.6 |
16% |
16.49 |
123.66 |
24.73 |
148.39 |
|
НСР-5741/26.02.2015.; НСР-10743/27.10.2016; НСР-13547/18.08.2017; НСР-15737/25.05.2018; НСР-17837/30.01.2019 |
14.02.2019 |
02.03.2019 |
Активен |
3632 |
| Lamivudine |
EU/1/96/015/001 |
EPIVIR, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom, GlaxoSmith Kline Pharmaceuticals S.A. Poland |
103.21 |
20.64 |
123.85 |
4% |
4.13 |
107.34 |
21.47 |
128.81 |
16% |
16.51 |
123.85 |
24.77 |
148.62 |
|
НСР-5741/26.02.2015.; НСР-10743/27.10.2016; НСР-13547/18.08.2017; НСР-15737/25.05.2018 |
09.06.2018 |
02.07.2018 |
Неактивен |
3632 |
| Lamivudine |
EU/1/96/015/001 |
EPIVIR, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom, GlaxoSmith Kline Pharmaceuticals S.A. Poland |
105.16 |
21.03 |
126.19 |
4% |
4.21 |
109.37 |
21.87 |
131.24 |
16% |
16.83 |
126.2 |
25.24 |
151.44 |
|
НСР-5741/26.02.2015.; НСР-10743/27.10.2016; НСР-13547/18.08.2017 |
02.09.2017 |
02.10.2017 |
Неактивен |
3632 |
| Lamivudine |
EU/1/96/015/001 |
EPIVIR, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom, GlaxoSmith Kline Pharmaceuticals S.A. Poland |
109.55 |
21.91 |
131.46 |
4% |
4.38 |
113.93 |
22.79 |
136.72 |
16% |
17.53 |
131.46 |
26.29 |
157.75 |
|
НСР-5741/26.02.2015.; НСР-10743/27.10.2016 |
02.12.2016 |
02.12.2016 |
Неактивен |
3632 |
| Lamivudine |
EU/1/96/015/001 |
EPIVIR, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom, GlaxoSmith Kline Pharmaceuticals S.A. Poland |
122.71 |
24.54 |
147.25 |
4% |
4.91 |
127.62 |
25.52 |
153.14 |
16% |
19.63 |
147.25 |
29.45 |
176.7 |
|
НСР-5741/26.02.2015. |
12.03.2015 |
12.03.2015 |
Неактивен |
3632 |
| Lamivudine |
EU/1/96/015/001 |
EPIVIR, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Wellcome Operations, United Kingdom, GlaxoSmith Kline Pharmaceuticals S.A. Poland |
122.75 |
24.55 |
147.3 |
4% |
4.91 |
127.66 |
25.53 |
153.19 |
16% |
19.64 |
147.3 |
29.46 |
176.76 |
|
КЦРР-2793/20.03.2013; НСР-360/03.07.2013 |
31.07.2013 |
31.07.2013 |
Неактивен |
3632 |
| Lamivudine |
EU/1/96/015/001 |
EPIVIR, Film coated tablet, 150, mg, Pack: 60 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Glaxo Operations UK Ltd ,Великобритания GlaxoSmithKline Pharmaceuticals S.A. Полша |
205.01 |
41 |
246.01 |
4% |
8.2 |
213.21 |
42.64 |
255.85 |
16% |
25 |
238.21 |
47.64 |
285.85 |
|
КЦ-1824/11.10.2010 |
16.11.2010 |
16.11.2010 |
Неактивен |
3632 |
| Lamivudine |
EU/1/96/015/002 |
EPIVIR, Oral solution, 10mg/ml - 240ml, mg, Pack: 1 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Aspen Bad Oldesloe GmbHIndustriestrasse 32-36 23843 Bad Oldesloe, Germany |
31.7 |
6.34 |
38.04 |
4% |
1.27 |
32.97 |
6.59 |
39.56 |
16% |
5.07 |
38.04 |
7.61 |
45.65 |
|
НСР-4992/05.11.2014; НСР- 9725/07.07.2016 г.; НСР-12562/05.05.2017; НСР-15080/23.02.2018; НСР-17264/14.11.2018 |
29.11.2018 |
02.12.2018 |
Активен |
3338 |
| Lamivudine |
EU/1/96/015/002 |
EPIVIR, Oral solution, 10mg/ml - 240ml, mg, Pack: 1 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Aspen Bad Oldesloe GmbHIndustriestrasse 32-36 23843 Bad Oldesloe, Germany |
32.02 |
6.4 |
38.42 |
4% |
1.28 |
33.3 |
6.66 |
39.96 |
16% |
5.12 |
38.42 |
7.68 |
46.1 |
|
НСР-4992/05.11.2014; НСР- 9725/07.07.2016 г.; НСР-12562/05.05.2017; НСР-15080/23.02.2018 |
10.03.2018 |
02.04.2018 |
Неактивен |
3338 |
| Lamivudine |
EU/1/96/015/002 |
EPIVIR, Oral solution, 10mg/ml - 240ml, mg, Pack: 1 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Aspen Bad Oldesloe GmbHIndustriestrasse 32-36 23843 Bad Oldesloe, Germany |
32.25 |
6.45 |
38.7 |
4% |
1.29 |
33.54 |
6.71 |
40.25 |
16% |
5.16 |
38.7 |
7.74 |
46.44 |
|
НСР-4992/05.11.2014; НСР- 9725/07.07.2016 г.; НСР-12562/05.05.2017 |
20.05.2017 |
02.06.2017 |
Неактивен |
3338 |
| Lamivudine |
EU/1/96/015/002 |
EPIVIR, Oral solution, 10mg/ml - 240ml, mg, Pack: 1 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Aspen Bad Oldesloe GmbHIndustriestrasse 32-36 23843 Bad Oldesloe, Germany |
32.66 |
6.53 |
39.19 |
4% |
1.31 |
33.97 |
6.79 |
40.76 |
16% |
5.23 |
39.2 |
7.84 |
47.04 |
|
НСР-4992/05.11.2014; НСР- 9725/07.07.2016 г. |
02.08.2016 |
02.08.2016 |
Неактивен |
3338 |
| Lamivudine |
EU/1/96/015/002 |
EPIVIR, Oral solution, 10mg/ml - 240ml, mg, Pack: 1 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Aspen Bad Oldesloe GmbHIndustriestrasse 32-36 23843 Bad Oldesloe, Germany |
32.72 |
6.54 |
39.26 |
4% |
1.31 |
34.03 |
6.81 |
40.84 |
16% |
5.24 |
39.27 |
7.85 |
47.12 |
|
НСР-4992/05.11.2014 |
19.11.2014 |
19.11.2014 |
Неактивен |
3338 |
| Lamivudine |
EU/1/96/015/002 |
EPIVIR, Oral solution, 10mg/ml - 240ml, mg, Pack: 1 |
Viiv Healthcare UK Ltd.,, Обединено Кралство |
Aspen Bad Oldesloe GmbHIndustriestrasse 32-36 23843 Bad Oldesloe, Germany |
32.74 |
6.55 |
39.29 |
4% |
1.31 |
34.05 |
6.81 |
40.86 |
16% |
5.24 |
39.29 |
7.86 |
47.15 |
|
НСР-1078/02.09.2013 |
18.09.2013 |
18.09.2013 |
Неактивен |
3338 |
| Eplerenone |
20150425 |
Eplerenone Accord, Film coated tablet, 25, mg, Pack: 28 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство; Wessling Hungary Kft., Унгария |
21.48 |
4.3 |
25.78 |
6% |
1.29 |
22.77 |
4.55 |
27.32 |
18% |
3.87 |
26.64 |
5.33 |
31.97 |
|
НСР-16720/30.08.2018 |
14.09.2018 |
02.10.2018 |
Активен |
16258 |
| Eplerenone |
20150426 |
Eplerenone Accord, Film coated tablet, 50, mg, Pack: 28 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство; Wessling Hungary Kft, Унгария |
21.48 |
4.3 |
25.78 |
6% |
1.29 |
22.77 |
4.55 |
27.32 |
18% |
3.87 |
26.64 |
5.33 |
31.97 |
|
НСР-16720/30.08.2018 |
14.09.2018 |
02.10.2018 |
Активен |
16259 |
| Eplerenone |
20160284 |
Eplerium, Film coated tablet, 25, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Hemopharm GmbH, Германия |
19.56 |
3.91 |
23.47 |
6% |
1.17 |
20.73 |
4.15 |
24.88 |
18% |
3.52 |
24.25 |
4.85 |
29.1 |
|
НСР-11257/22.12.2016 |
07.01.2017 |
02.02.2017 |
Активен |
15553 |
| Eplerenone |
20110642 |
Eplerium, Film coated tablet, 25, mg, Pack: 30 |
Stada Arzneimittel AG, Германия |
Laboratorios Liconsa S.A., Испания |
41.72 |
8.34 |
50.06 |
4% |
1.67 |
43.39 |
8.68 |
52.07 |
16% |
6.68 |
50.07 |
10.01 |
60.08 |
Цената се заличава с решение НСР-4777/13.10.2014 ( в сила от 27.10.2014) |
НСР-2909/05.03.2014 |
20.03.2014 |
20.03.2014 |
Заличен |
2559 |
| Erythropoietin(Epoetin theta) |
EU/1/09/573/008 |
Eporatio, Solution for injection, 4000, IU, Pack: 6 |
Ratiopharm GmbH, Германия |
Merckle Biotec GmbH, Dornierstrasse 10, DE-89079 Ulm, Germany |
241.64 |
48.33 |
289.97 |
4% |
9.67 |
251.31 |
50.26 |
301.57 |
16% |
25 |
276.31 |
55.26 |
331.57 |
Цената се вписва в регистъра на пределните цени с решение НСР-4555/03.09.2014 ( в сила от 18.09.2014) |
НСР-3699/06.06.2014 |
23.06.2014 |
23.06.2014 |
Заличен |
2910 |
| Erythropoietin(Epoetin theta) |
EU/1/09/573/010 |
Eporatio, Solution for injection, 5000, IU, Pack: 6 |
Ratiopharm GmbH, Германия |
Merckle Biotec GmbH, Dornierstrasse 10, DE-89079 Ulm, Germany |
302.06 |
60.41 |
362.47 |
4% |
10 |
312.06 |
62.41 |
374.47 |
16% |
25 |
337.06 |
67.41 |
404.47 |
корекц. решение НСР-4177/23.07.2014; Цената се вписва в регистъра на пределните цени с решение НСР-4555/03.09.2014 ( в сила от 18.09.2014) |
НСР-3699/06.06.2014 |
23.06.2014 |
23.06.2014 |
Заличен |
2911 |
| Erythropoietin(Epoetin theta) |
EU/1/09/573/006 |
Eporatio, Solution for injection, 3000, IU, Pack: 6 |
Ratiopharm GmbH, Германия |
Merckle Biotec GmbH, Dornierstrasse 10, DE-89079 Ulm, Germany |
181.23 |
36.25 |
217.48 |
4% |
7.25 |
188.48 |
37.7 |
226.18 |
16% |
25 |
213.48 |
42.7 |
256.18 |
Цената се вписва в регистъра на пределните цени с решение НСР-4555/03.09.2014 ( в сила от 18.09.2014) |
НСР-3698/06.06.2014 |
23.06.2014 |
23.06.2014 |
Заличен |
2909 |